These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 3043956

  • 21. [Experiences with Ossin].
    Kocián J.
    Med Pregl; 1980; 33(7-8):309-16. PubMed ID: 7010110
    [No Abstract] [Full Text] [Related]

  • 22. [Treatment of osteoporosis].
    Yamazaki K, Inoue T.
    Nihon Rinsho; 1990 Dec; 48(12):2916-21. PubMed ID: 2086855
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Therapeutic choices in osteoporosis].
    Burckhardt P.
    Schweiz Med Wochenschr; 1987 Jan 17; 117(3):75-83. PubMed ID: 3823821
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Osteoporosis: significance, risk factors and treatment.
    Coralli CH, Raisz LG, Wood CL.
    Nurse Pract; 1986 Sep 17; 11(9):16-20, 25-7, 30 passim. PubMed ID: 3763061
    [Abstract] [Full Text] [Related]

  • 27. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K, Josse RG.
    CMAJ; 1996 Oct 01; 155(7):962-5. PubMed ID: 8837547
    [Abstract] [Full Text] [Related]

  • 28. Osteoporosis: new hope for the future.
    Masi L, Bilezikian JP.
    Int J Fertil Womens Med; 1997 Oct 01; 42(4):245-54. PubMed ID: 9309458
    [Abstract] [Full Text] [Related]

  • 29. Treatment of anticonvulsant drug-induced bone disease.
    Drezner MK.
    Epilepsy Behav; 2004 Feb 01; 5 Suppl 2():S41-7. PubMed ID: 15123011
    [Abstract] [Full Text] [Related]

  • 30. [Effect of vitamin D on muscle strength and relevance in regard to osteoporosis prevention].
    Bischoff-Ferrari HA, Conzelmann M, Dick W, Theiler R, Stähelin HB.
    Z Rheumatol; 2003 Dec 01; 62(6):518-21. PubMed ID: 14685712
    [Abstract] [Full Text] [Related]

  • 31. Osteoporosis.
    Lane JM, Vigorita VJ.
    Orthop Clin North Am; 1984 Oct 01; 15(4):711-28. PubMed ID: 6387578
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Senile osteoporosis--prevention and therapy].
    Ringe JD.
    Z Gerontol; 1993 Oct 01; 26(1):34-8. PubMed ID: 8465579
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Contribution to the study of the treatment of osteoporosis using fluoride. Long-term sequelae following discontinuation of fluoride].
    van Linthoudt D, Baud CA, Courvoisier B, Ott H.
    Schweiz Med Wochenschr; 1988 Aug 27; 118(34):1199-201. PubMed ID: 3175569
    [Abstract] [Full Text] [Related]

  • 36. [Multidisciplinary study of the prolonged treatment of involution osteoporosis using sodium fluoride with calcium, phosphate and vitamin D].
    Courvoisier B, Baud CA, Véry JM, Assimacopoulos A, Tochon-Danguy HJ, Boivin G, Donath A, Garcia J, Gasser A, Fischer J.
    Schweiz Med Wochenschr; 1985 Jul 09; 115(27-28):922-31. PubMed ID: 4023678
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Effects of the treatment of active osteoporosis on the urinary excretion of hydroxyproline].
    Rico Lenza H, del Rio Vázquez A, Vázquez Salamanica E, Espinos Pérez D.
    Rev Clin Esp; 1979 Apr 30; 153(2):103-6. PubMed ID: 482672
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.